BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 38158115)

  • 1. Doxycycline hydrochloride inhibits the progress of malignant rhabdoid tumor of kidney by targeting MMP17 and MMP1 through PI3K-Akt signaling pathway.
    Mi T; Zhang Z; Zhanghuang C; Jin L; Tan X; Liu J; Wu X; Li M; Wang J; Wang Z; Guo P; He D
    Eur J Pharmacol; 2024 Feb; 964():176291. PubMed ID: 38158115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BKM120 inhibits malignant rhabdoid tumor of the kidney through induction of apoptosis and G0/G1 phase arrest.
    Liu J; Mi T; Zhang Z; Jin L; Li M; Zhanghuang C; Li M; Wang J; Wu X; Wang Z; Tan X; Wang Z; He D
    Eur J Pharmacol; 2023 Jul; 951():175747. PubMed ID: 37142086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Doxycycline Hydrochloride Regulates Cytoskeletal Rearrangement and Epithelial-To-Mesenchymal Transition in Malignant Rhabdoid Tumour of the Kidney.
    Zhanghuang C; Zhang Z; Mi T; Wang J; Jin L; Liu J; Li M; Li M; Wu X; Wang Z; He D
    Biomed Res Int; 2022; 2022():2760744. PubMed ID: 36408277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Wogonin Restrains the Malignant Progression of Lung Cancer Through Modulating MMP1 and PI3K/AKT Signaling Pathway.
    Guo J; Jin G; Hu Y; Zhao Z; Nan F; Hu X; Hu Y; Han Q
    Protein Pept Lett; 2023; 30(1):25-34. PubMed ID: 36305146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Knockdown of MMP‑1 inhibits the progression of colorectal cancer by suppressing the PI3K/Akt/c‑myc signaling pathway and EMT.
    Wang K; Zheng J; Yu J; Wu Y; Guo J; Xu Z; Sun X
    Oncol Rep; 2020 Apr; 43(4):1103-1112. PubMed ID: 32323782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of Prognostic Biomarkers in Patients With Malignant Rhabdoid Tumor of the Kidney Based on mTORC1 Signaling Pathway-Related Genes.
    Zhanghuang C; Yao Z; Tang H; Zhang K; Wu C; Li L; Xie Y; Yang Z; Yan B
    Front Mol Biosci; 2022; 9():843234. PubMed ID: 35558559
    [No Abstract]   [Full Text] [Related]  

  • 7. MMP1 promotes tumor growth and metastasis in esophageal squamous cell carcinoma.
    Liu M; Hu Y; Zhang MF; Luo KJ; Xie XY; Wen J; Fu JH; Yang H
    Cancer Lett; 2016 Jul; 377(1):97-104. PubMed ID: 27130665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of stage IV malignant rhabdoid tumor of the kidney (MRTK) with ICE and VDCy: a case report.
    Yamamoto M; Suzuki N; Hatakeyama N; Mizue N; Hori T; Kuroiwa Y; Hareyama M; Oda T; Kudoh T; Nui A; Matsuno T; Hirama T; Yokoyama S; Dome JS; Tsutsumi H
    J Pediatr Hematol Oncol; 2006 May; 28(5):286-9. PubMed ID: 16772877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MiR-155-5p exerts tumor-suppressing functions in Wilms tumor by targeting IGF2 via the PI3K signaling pathway.
    Luo X; Dong J; He X; Shen L; Long C; Liu F; Liu X; Lin T; He D; Wei G
    Biomed Pharmacother; 2020 May; 125():109880. PubMed ID: 32004974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and metastatic potential of tumor-initiating cells in malignant rhabdoid tumor of the kidney.
    Yanagisawa S; Kadouchi I; Yokomori K; Hirose M; Hakozaki M; Hojo H; Maeda K; Kobayashi E; Murakami T
    Clin Cancer Res; 2009 May; 15(9):3014-22. PubMed ID: 19383826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. β-elemene Suppresses Migration of Esophageal Squamous Cell Carcinoma by Modulating Expression of MMP9 through the PI3K/Akt/NF-κB Pathway.
    Liang Y; Li S
    Comb Chem High Throughput Screen; 2023; 26(13):2304-2320. PubMed ID: 36872359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and Molecular Differentiation Between Malignant Rhabdoid Tumor of the Kidney and Normal Tissue: A Two-Case Report.
    Zhanghuang C; Chen S; Li L; Yang Z; Xie Y; Li J; Tang H; He X; Dong L; Yan B
    Front Oncol; 2021; 11():659709. PubMed ID: 33859949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MMP11 and MMP17 are potential biomarkers for uterine corpus endometrial carcinoma prognosis.
    Zhang Y; Wang J; Fan Y; Lang F; Fu F; Liu Q
    Clin Transl Oncol; 2024 Mar; 26(3):653-663. PubMed ID: 37523078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LncRNA WTAPP1 Promotes Migration and Angiogenesis of Endothelial Progenitor Cells via MMP1 Through MicroRNA 3120 and Akt/PI3K/Autophagy Pathways.
    Li WD; Zhou DM; Sun LL; Xiao L; Liu Z; Zhou M; Wang WB; Li XQ
    Stem Cells; 2018 Dec; 36(12):1863-1874. PubMed ID: 30171660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dependence on PI3K/Akt signaling for malignant rhabdoid tumor cell survival.
    Foster K; Wang Y; Zhou D; Wright C
    Cancer Chemother Pharmacol; 2009 Apr; 63(5):783-91. PubMed ID: 18641990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting of SPP1 by microRNA-340 inhibits gastric cancer cell epithelial-mesenchymal transition through inhibition of the PI3K/AKT signaling pathway.
    Song SZ; Lin S; Liu JN; Zhang MB; Du YT; Zhang DD; Xu WH; Wang HB
    J Cell Physiol; 2019 Aug; 234(10):18587-18601. PubMed ID: 30953349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Silibinin inhibits migration and invasion of the rhabdoid tumor G401 cell line via inactivation of the PI3K/Akt signaling pathway.
    Li Y; Zhang C; Cai D; Chen C; Mu D
    Oncol Lett; 2017 Dec; 14(6):8035-8041. PubMed ID: 29344246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Down-regulation of mir-27b promotes angiogenesis and fibroblast activation through activating PI3K/AKT signaling pathway.
    Sun F; Bi Q; Wang X; Liu J
    Wound Repair Regen; 2020 Jan; 28(1):39-48. PubMed ID: 31587435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TEAD4 functions as a prognostic biomarker and triggers EMT via PI3K/AKT pathway in bladder cancer.
    Chi M; Liu J; Mei C; Shi Y; Liu N; Jiang X; Liu C; Xue N; Hong H; Xie J; Sun X; Yin B; Meng X; Wang B
    J Exp Clin Cancer Res; 2022 May; 41(1):175. PubMed ID: 35581606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identity of MMP1 and its effects on tumor progression in head and neck squamous cell carcinoma.
    Zhang G; Li T; Tan G; Song Y; Liu Q; Wang K; Ai J; Zhou Z; Li W
    Cancer Med; 2022 Jun; 11(12):2516-2530. PubMed ID: 35426219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.